uPAR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of uPAR monoclonal antibodies for various research applications. uPAR Antibodies targeting urokinase plasminogen activator receptor (uPAR) are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The urokinase plasminogen activator receptor (uPAR) plays a critical role in cell migration, tissue remodeling, and the regulation of proteolytic activity, making it significant in processes such as wound healing and cancer metastasis. Expression levels of urokinase plasminogen activator receptor (uPAR) are often associated with various pathological conditions, including inflammatory diseases and tumors. Understanding urokinase plasminogen activator receptor (uPAR) function has become increasingly important in cancer research and therapeutic development. Researchers worldwide utilize urokinase plasminogen activator receptor (uPAR) monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms. Advanced research techniques and protocols have enhanced the detection and analysis of urokinase plasminogen activator receptor (uPAR) in diverse biological samples. Santa Cruz Biotechnology monoclonal antibodies targeting urokinase plasminogen activator receptor (uPAR) continue to support breakthrough discoveries in biomedical research and therapeutic development.